Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise

ST Muyao (600671): Report on the performance of the Audit Committee of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. in 2021 CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Report on the performance of the Audit Committee of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. in 2021 CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Independent opinion of the independent director of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the internal control audit report issued by the accounting firm with negative opinion- CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Resolution of the 8th meeting of the 11th Supervisory Committee of Hangzhou Tianmushan Pharmaceutical Co., Ltd. CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Notice of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on Holding the 2021 Annual General Meeting of Shareholders- CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

[Guarantee] ST Muyao (600671): Special explanation and independent opinion of the independent director of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the company's external guarantee in 2021- CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

[Warning] ST Muyao (600671): Hangzhou Tianmushan Pharmaceutical Co., Ltd. continues to implement other risk warnings on the company's stock CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Opinions of the Supervisory Committee of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the "Special Explanation of the Board of Directors on the Matters Involved in the Auditing Report Issued by an Accounting Firm with a Qualified Opinion" CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Opinions of the Supervisory Committee of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the "Special Explanation of the Board of Directors on Internal Control Audit Reports Issued by Accounting Firms with Negative Opinions" CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Resolution of the 12th meeting of the 11th Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Independent opinion of the independent directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on matters related to the 12th meeting of the 11th board of directors of the company- CFi.CN Zhongcai.com

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Special Explanation of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the Internal Control Audit Report Issued by the Accounting Firm CFi.CN Zhongcai.com

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671): Report on the performance of the Audit Committee of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. in 2021 CFi.CN Zhongcai Network

  • Post date May 1, 2022 — 01:23 Post Lock Login to View

Read More

ST Muyao (600671.SH) released 2021 results, with a net loss of 29.8 million yuan – yqqlm

  • Post date April 29, 2022 — 21:23 Post Lock Login to View

Read More

ST Muyao (600671.SH) released its 2021 results, with a net loss of 29.8 million yuan – yqqlm

  • Post date April 29, 2022 — 21:23 Post Lock Login to View

Read More

There is only 1 year left in the statute of limitations for the lawsuit, and Tianmu Pharmaceutical's fine has finally landed! Bai Baolong received tens of millions of fines, how can shareholders file a claim?

  • Post date April 25, 2022 — 00:47 Post Lock Login to View

Read More

Tianmu Pharmaceutical was punished, and investor claims are being collected – yqqlm

  • Post date April 21, 2022 — 13:54 Post Lock Login to View

Read More

The former capital empire collapsed! The last A-share listing was terminated, and ​30,000 shareholders suffered! The debt is nearly 1 billion, and the annual revenue is only more than 2 million! _Shenzhen Hotline

  • Post date April 20, 2022 — 20:53 Post Lock Login to View

Read More

The Great Wall Department has fully retreated from A-shares! Lost 1.5 billion in 4 years, *ST Changdong enters the countdown to delisting Zhao Ruiyong – yqqlm

  • Post date April 20, 2022 — 20:01 Post Lock Login to View

Read More

Forced delisting! I once dreamed of building "Oriental Disney", but now the stock price is only 1 yuan, and it lost 1.5 billion in 4 years. The father and son of the original controller were also offered a reward of 13 million.

  • Post date April 20, 2022 — 19:56 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.